Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
Robin Carhart‐Harris, Robert Leech, Peter J. Hellyer, et al.
Frontiers in Human Neuroscience (2014) Vol. 8
Open Access | Times Cited: 1017

Showing 1-25 of 1017 citing articles:

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1181-1197
Open Access | Times Cited: 1689
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross, Anthony P. Bossis, Jeffrey Guss, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1165-1180
Open Access | Times Cited: 1332
Psychedelics
David E. Nichols
Pharmacological Reviews (2016) Vol. 68, Iss. 2, pp. 264-355
Open Access | Times Cited: 1293
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin Carhart‐Harris, Suresh Muthukumaraswamy, Leor Roseman, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 17, pp. 4853-4858
Open Access | Times Cited: 750
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson, Albert Garcia‐Romeu, Mary P Cosimano, et al.
Journal of Psychopharmacology (2014) Vol. 28, Iss. 11, pp. 983-992
Open Access | Times Cited: 746
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 636
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 591
How Breath-Control Can Change Your Life: A Systematic Review on Psycho-Physiological Correlates of Slow Breathing
Andrea Zaccaro, Andrea Piarulli, Marco Laurino, et al.
Frontiers in Human Neuroscience (2018) Vol. 12
Open Access | Times Cited: 492
Mapping the self in the brain's default mode network
Christopher G. Davey, Jesùs Pujol, Ben J. Harrison
NeuroImage (2016) Vol. 132, pp. 390-397
Open Access | Times Cited: 490
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin Carhart‐Harris, Leor Roseman, Mark Bolstridge, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 464
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin Reiff, Elon E. Richman, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2020) Vol. 177, Iss. 5, pp. 391-410
Closed Access | Times Cited: 446
Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
Enzo Tagliazucchi, Leor Roseman, Mendel Kaelen, et al.
Current Biology (2016) Vol. 26, Iss. 8, pp. 1043-1050
Open Access | Times Cited: 441
The entropic brain - revisited
Robin Carhart‐Harris
Neuropharmacology (2018) Vol. 142, pp. 167-178
Closed Access | Times Cited: 432
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson, Peter S. Hendricks, Frederick S. Barrett, et al.
Pharmacology & Therapeutics (2018) Vol. 197, pp. 83-102
Closed Access | Times Cited: 419
Understanding the Higher-Order Approach to Consciousness
Richard Brown, Hakwan Lau, Joseph E. LeDoux
Trends in Cognitive Sciences (2019) Vol. 23, Iss. 9, pp. 754-768
Open Access | Times Cited: 419
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 405
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser, Katharina Kirchner, Torsten Passie
Journal of Psychopharmacology (2014) Vol. 29, Iss. 1, pp. 57-68
Closed Access | Times Cited: 399
Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)
Matthew M. Nour, Lisa Evans, David Nutt, et al.
Frontiers in Human Neuroscience (2016) Vol. 10
Open Access | Times Cited: 376
Enhanced repertoire of brain dynamical states during the psychedelic experience
Enzo Tagliazucchi, Robin Carhart‐Harris, Robert Leech, et al.
Human Brain Mapping (2014) Vol. 35, Iss. 11, pp. 5442-5456
Open Access | Times Cited: 373
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
Michael Schartner, Robin Carhart‐Harris, Adam B. Barrett, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 362
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Peter S. Hendricks, Christopher B. Thorne, C. Brendan Clark, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 3, pp. 280-288
Closed Access | Times Cited: 339
Psychedelics, Meditation, and Self-Consciousness
Raphaël Millière, Robin Carhart‐Harris, Leor Roseman, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 305
Psychedelics as Medicines: An Emerging New Paradigm
DE Nichols, MW Johnson, CD Nichols
Clinical Pharmacology & Therapeutics (2016) Vol. 101, Iss. 2, pp. 209-219
Closed Access | Times Cited: 296
Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin
Alexander V. Lebedev, Martin Lövdén, Gidon Rosenthal, et al.
Human Brain Mapping (2015) Vol. 36, Iss. 8, pp. 3137-3153
Open Access | Times Cited: 292
Page 1 - Next Page

Scroll to top